Physician profile
Carlos E Marchini
NPI 1720088677
$2,220.95
in general payments reported to CMS, 2019-2025
10 companies · $806 in 2025
The $806 reported for 2025 was more than what a typical Pulmonary Disease provider received nationally (typical 2025 total: $500).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $28.11 · 2021: $22.83 · 2022: $42.99 · 2023: $526 · 2024: $795 · 2025: $806.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $820 · Consulting Fee: $750 · Education: $557.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $820.02 |
| Consulting Fee | $750.00 |
| Education | $557.00 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Bayer Healthcare Pharmaceuticals INC. | $600.00 | 2023-2025 | |
| Jazz Pharmaceuticals INC. | $495.74 | 2023-2025 | |
| Glaxosmithkline, LLC. | $369.55 | 2019-2025 | Nucala, Arexvy, Trelegy Ellipta |
| Astrazeneca Pharmaceuticals Lp | $301.94 | 2023-2025 | Breztri, Airsupra |
| Sanofi-Aventis U.S. LLC | $269.97 | 2023-2025 | |
| Regeneron Healthcare Solutions, INC. | $79.94 | 2024 | Dupixent |
| Insmed, INC. | $47.10 | 2022-2025 | Arikayce, Brinsupri |
| Harmony Biosciences LLC | $31.50 | 2023-2025 | Wakix |
| Sunovion Pharmaceuticals INC. | $12.71 | 2019 | |
| Baxter Healthcare | $12.50 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Carlos Marchini listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.